Commence Secures Position on $3.5B CMS RMADA 3 IDIQ, Expanding Its Role in Federal Health Policy Research and Model Evaluation

Commence won a prime spot on the $3.5B CMS RMADA 3 IDIQ, expanding its federal health policy research and model evaluation work. The award supports near-term visibility into government contracting activity, though the article does not quantify financial impact to Commence beyond the program size.

Analysis

Commence won a prime spot on the $3.5B CMS RMADA 3 IDIQ, expanding its federal health policy research and model evaluation work. The award supports near-term visibility into government contracting activity, though the article does not quantify financial impact to Commence beyond the program size.